Ewart R, Bradford M
Department of Medicine, University of Louisville School of Medicine, Kentucky.
Life Sci. 1988;42(25):2587-92. doi: 10.1016/0024-3205(88)90327-x.
In the study reported, colchicine, often regarded as a specific inhibitor of microtubular function, was shown to exert a concentration-dependent inhibition of the low Km cyclic AMP phosphodiesterases of the pancreatic islet, adrenal cortex and various other tissues of the rat. The results indicated that colchicine is only slightly less active as an inhibitor of the enzyme than theophylline on a molar basis and kinetic analysis revealed that both inhibitors acted competitively in the case of the liver enzyme. Our results show that the inhibitory effect of colchicine upon cyclic AMP phosphodiesterase is a general property of the alkaloid at concentrations of 5 x 10(-5)M and above in both endocrine and non-endocrine tissues. Thus, results obtained employing colchicine at concentrations significantly greater than those which are known to lead to microtubular disaggregation must be viewed with great caution if incorrect implication of microtubular participation in biological processes is to be avoided. For example, we propose that the previously reported paradoxical stimulatory effects of colchicine on the secretion of glucagon from the rat pancreatic islet and on steroidogenesis in the rat adrenal may be due to cyclic AMP accumulation consequent upon phosphodiesterase inhibition in these endocrine tissues and not to microtubular disaggregation as has hitherto been assumed.
在所报道的研究中,秋水仙碱常被视为微管功能的特异性抑制剂,结果显示它对大鼠胰岛、肾上腺皮质及其他多种组织中的低 Km 环磷酸腺苷磷酸二酯酶具有浓度依赖性抑制作用。结果表明,以摩尔计,秋水仙碱作为该酶抑制剂的活性仅略低于茶碱,动力学分析表明,对于肝脏中的该酶,两种抑制剂均起竞争性抑制作用。我们的结果表明,在浓度为 5×10(-5)M 及以上时,秋水仙碱对环磷酸腺苷磷酸二酯酶的抑制作用是该生物碱在内分泌和非内分泌组织中的普遍特性。因此,如果要避免错误地认为微管参与生物过程,那么在使用浓度显著高于已知会导致微管解聚的秋水仙碱时,所得结果必须谨慎看待。例如,我们认为先前报道的秋水仙碱对大鼠胰岛胰高血糖素分泌及大鼠肾上腺类固醇生成的矛盾性刺激作用,可能是由于这些内分泌组织中磷酸二酯酶受抑制后导致环磷酸腺苷积累,而不是如迄今所认为的那样是由于微管解聚。